Two important factors suggest that the abuse and misuse of alcohol, psychoactive medications, illicit drugs, and nicotine among the elderly has become a significant public health concern for the next several decades. First, there is a growing literature demonstrating that the abuse or dependence on these substances is common and adversely affects a growing proportion of the elderly population. Further compounding this problem is the expected doubling of the elderly population over the next two decades. Second, the elderly represent a group of adults who are particularly vulnerable to the effects of these substances, and, as such, there is a need for a paradigm shift in the way clinicians and researchers think about diagnosis and the risks of use in this segment of the population. This is highlighted by the growing literature demonstrating the negative health consequences of alcohol at consumption levels previously thought of as moderate and certainly not thought of as correlating with a diagnosis of alcohol dependence. The articles contained in this focused edition of the Journal highlight both of these aspects of late-life addiction and provide a ray of optimism in the ability to face the treatment challenges presented by older adults.
Prevalence estimates of older problem drinking using community surveys have ranged from 1% to 15%.14 These rates vary widely depending on the definition of problem drinking or alcohol abuseldependence and the methodology used in obtaining samples. In health care settings, the prevalence of alcohol use problems, as well as other addiction problems, has been demonstrated to be even higher.5Although less well studied as an addiction problem, in this issue Llorente et a1 point out that benzodiazepines continue to be used at high rates in the elderly and pose significant risks for this vulnerable population. The current prevalence rates suggest that the use of these substances is already the basis of significant public health burden. This burden will be compounded by the increase in the senior population. Current census estimates predict that, by the year 2020, 18% of the population will be 65 years or older, representing an increase from our current elderly population of 30 million older adults to over 50 million older adults?
In addition to the increase in the absolute number of older adults and the increase in the number of addiction problems seen in this age group, there is speculation that the overall prevalence of the use of these substances will also rise. Two factors that may. contribute to increased prevalence rates are the improved health of older adults, especially those in their sixties, and cohort differences. A long-held reality of addictions is that declining health and frailty are some of the greatest motivations for changing an addictive behavior, and this decline often leads to abstinence in many older adults. Advances in medical science have led to ever healthier seniors, which for some will lessen the motivation for change and may lead to longer drinking or drug use careers.
The second effect on prevalence rates has to do with speculation about cohort changes. The current group of elders grew up at a time in which there were significant negative moral attitudes regarding alcohol consumption, especially for women. This same group of elders also had relatively low exposure to illicit drug use and limited exposure to the explosion of psychopharmacologic agents available today. In addition, although it is often forgotten, cigarette use was practically nonexistent prior to the turn of the century. In contrast, the coming generation of elders (the "Baby Boom" generation) grew up in a time of tremendous social unrest in which there was experimentation with both licit and illicit drugs. "he contrast in the two cohorts may translate into greater elder misuse of substances. The article by Schonfeld et a1 supports this hypothesis with the large percentage of their treatment population who were addicted to illicit drugs either in combination with alcohol or by themselves. This is contrasted with the very low prevalence rates of illicit drug use reported in other studies.2 However, both of these arguments for rising prevalence rates, although holding a certain amount of face validity, are clearly Journal of Geriatric Psychiatry and Neurology I Vol. 13, Fall 2000 hypotheses that are untested. It is possible that there may be no change in prevalence rates during the next two decades. Future research will be needed to address these hypotheses.
Putting aside the possible increases in prevalence over time, the current rate of substance use problems in this population will continue to strain the health care system. This burden on the health care system is most likely due to a lack of knowledge regarding the effects of late-life addictions and knowledge regarding treatment of these disorders. The encouraging news from the group of articles in this special issue is that alcohol abuse, in particular, is amenable to treatment in a large proportion of patients. Both the study conducted by Schonfeld et a1 and the brief intervention studies reviewed by Blow and Barry show positive results regarding treatment outcomes. Previous work has also demonstrated that using naltrexone, as well as age-specific group therapy, is effective with elder^.^ As reviewed by Llorente et al, a few studies have also demonstrated positive findings in reducing benzodiazepine use. hlore studies on other addictions including interventions for smoking, gambling, and illicit drug use are needed.
Despite the effective interventions available, seniors are not accessing care for these problems. Although it is true that substance dependence has been accepted by the medical community as a cause of significant disability that warrants treatment, many older adults are not recognized as having problems related to their substance use. This is partly because the diagnostic criteria are oRen difficult to interpret and not applied in a consistent manner for older adults. For example, many elders drink a t home by themselves and are less likely to be arrested, have arguments, or have employment problems. Moreover, because many of the diseases caused by or affected by alcohol use such as hypertension, stroke, and pulmonary disease are common disorders in late life, physicians may overlook the effects of drinking. This is consistent with the literature that demonstrates that older problem drinkers are identified less often by clinicians and are less often referred for treatment than their younger counterparts? As noted in the article by Conigliaro et al, one solution to this problem is structured screening methods that identify those with problems. A key to screening for substance use disorders is having a structured follow-up and referral process. Physicians must be willing to screen for substance problems and encourage and facilitate treatment.
Given that many older adults with problems related to substance use are not identified, there has been growing interest in thinking about substance use in the elderly in terms of prevention and early intervention. This is supported by the growing literature demonstrating significant disability from moderate use of substances wvithout a substance dependence diagnosis. The articles by Oslin and by Saxton et a1 are important in this aspect. Both of these articles point to the effects of both moder-ate and heavier alcohol use on problems such as cognition, depression, and chronic medical problems. Indeed, these effects are seen at relatively low levels of consumption. These data suggest that reductions in consumption could be beneficial and that interventions designed to address this level of consumption, such as brief interventions, are warranted. On the other hand, we should be clear that drinking one or two drinks per day in the context of a chronic illness is probably not alcohol dependence in the sense of a psychiatric illness. Substance dependence is an illness that involves impairment in craving, reward, or satiety. The risks associated with more moderate substance use are better conceptualized as abusive or at-risk use. At-risk use is defined as consuming a substance at a level that places the individual at risk for problems or leads to problems, such as the exacerbation of a chronic medical or mental health problem, but does not meet criteria for substance dependence. The utility of identifying patients with at-risk substance use, as opposed to a diagnosable substance use disorder, is both the ease of implementation and the ability to have a mechanism for introducing prevention messages for mental health problems. At-risk use is generally screened for and identified solely based on the quantity and frequency of yse rather than diagnostic criteria.
As we prepare for the next several decades, it is useful to reflect on the literature at hand and propose avenues for future investigation. Aprincipal area of concern is demonstrating that reductions in substance use (e.g., alcohol or benzodiazepines) actually have benefit. To date, the majority of studies have focused on compliance with treatment and demonstrating that treatments are effective in reducing use. For the most part, treatment studies such as those in this edition have shown positive outcomes. However, there continues to be skepticism among patients, families, and clinicians regarding the benefits of reducing both moderate and heavier alcohol consumption or benzodiazepine use. This skepticism is likely fueled by the lack of information of the effects of treatment on quality of life, physical or mental well-being, social function, or other areas of living. There are also likely lingering ageist attitudes leading to a perception that older adults should "have their enjoyment in life" and changes in drinking should not be imposed when there appears to be no perceived risk or harm to others. The corollary is that there are benefits for reducing substance use in earlier life because of improved production in employment, a decrease in legal problems, reductions in trauma including that from drinking and driving, and a decrease in spousal and child abuse.
Similar to the effects of current alcohol use on disability is the need to better understand prior histories of substance abuse on disability. As an example, cigarette smoking is known to increase cancer risk and respiratory problems in late life. Very limited data suggest that a history of heavy alcohol use in young adulthood does impact on the presentation of depression or dementia in late life? Other evidence suggests that alcohol abuse in young adulthood affects the rate of recovery from physical disability.1° Still unknown are the effects of other types of early adulthood substance abuse, such as opioid or cocaine dependence, on the aging process or on the Course or prognosis of late-life disorders. Since cocaine use acutely affects dopamine neurotransmission, there is a question if this use will increase the vulnerability to movement disorders or Parkinson's disease later in life.
From an educational standpoint, there is a critical need for an increase in the dissemination of state-of-theart information regarding substance use problems in later life. Few clinicians receive any formal training in issues related to late-life substance abuse and, as noted by the Llorente et a1 article, evidence suggests that benzodiazepines continue to be used somewhat indiscriminately, suggesting a lack of knowledge regarding proven indications. Further education of patients and families is also indicated. A large proportion of public service information is appropriately focused on prevention of mental illness and substance use among young adults and teenagers, but more efforts are imperative for geriatric issues. On a positive note regarding the education of clinicians, several federal agencies and fraternal organizations such as the American Society on Aging, the American Association for Geriatric Psychiatrists, the Center for Substance Abuse Prevention, and the American Academy of Addiction Psychiatrists have all supported seminars or featured symposium over the last year on late-life substance misuse.
A final critical area of need is more emphasis on research. This is crucial on several levels including funding, developing a generation of new investigators, and encouraging current investigators to expand studies to include late-life issues. The vast majority of research fmding for mental illness comes from the National Institutes of Health (NIH), with little private funding available.
However, there are few currently funded projects from NIH focusing on late-life substance abuse. One immediate improvement in this regard will be to encourage investigators to include older adults in research projects. Limiting addiction research to those under the age of 65 does not take into account the fact that the illness does not stop at that age. Broadening the focus of research efforts in substance use, at-risk use, problem use, and abusefdependence to include all age groups, including older adults, will be crucial in the development of interventions and treatments targeted to the specific needs and issues of individuals across the lifespan.
